Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market
The Nasdaq Stock Market announced the delisting of several companies: Better Therapeutics, Tritium DCFC, Arcimoto, Next.e.GO, Acutus Medical, and NeuBase Therapeutics.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The Nasdaq Stock Market announced the delisting of several companies: Better Therapeutics, Tritium DCFC, Arcimoto, Next.e.GO, Acutus Medical, and NeuBase Therapeutics.
These companies had their securities suspended on various dates between March 18, 2024, and May 13, 2024, and have not traded since their respective suspension dates. This action underscores the importance of adhering to Nasdaq's listing requirements.
For more detailed information, Nasdaq’s rules on delisting can be accessed on their official website.
Positive
- Action underscores Nasdaq's adherence to strict listing requirements, ensuring market integrity.
- Potential for remaining companies on Nasdaq to gain confidence from investors due to rigorous enforcement of rules.
Negative
- Six companies being delisted could indicate potential financial instability in these firms.
- Investors in Better Therapeutics, Tritium DCFC, Arcimoto, Next.e.GO, Acutus Medical, and NeuBase Therapeutics may suffer significant losses due to delisting.
- Suspension and subsequent delisting suggest possible non-compliance or financial struggles within these companies.
Details
News Market Reaction – NDAQ
The recorded move for NDAQ in the trading session of this news was +1.43%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.’s securities were suspended on March 18, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares and warrants of Tritium DCFC Limited. Tritium DCFC Limited’s securities were suspended on April 22, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Arcimoto, Inc. Arcimoto, Inc.’s securities were suspended on May 1, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares of Next.e.GO N.V.. Next.e.GO N.V.’s securities were suspended on May 1, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Acutus Medical, Inc. Acutus Medical, Inc.’s securities were suspended on May 9, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.’s securities were suspended on May 13, 2024, and have not traded on Nasdaq since that time.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.